Basic Information
| LncRNA/CircRNA Name | PANDAR |
| Synonyms | PANDAR, PANDA |
| Region | GRCh38_6:36673621-36675126 |
| Ensemble | ENSG00000281450 |
| Refseq | NR_109836 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR, Western blot |
| Sample | thyroid tumor tissue, cell lines (K-1, TPC-1, SW579, FTC133 and XTC-1) |
| Expression Pattern | up-regulated |
| Function Description | We found that expression of PANDAR was up-regulated in thyroid cancer tissues compared with adjacent non-tumor tissues. |
| Pubmed ID | 28507479 |
| Year | 2017 |
| Title | Knockdown of lncRNA-PANDAR suppresses the proliferation, cell cycle and promotes apoptosis in thyroid cancer cells |
External Links
| Links for PANDAR | GenBank HGNC NONCODE |
| Links for thyroid cancer | OMIM COSMIC |